Kathleen Merrigan

All filings by Kathleen Merrigan on record concern Marrone Bio Innovations Inc. Activity is concentrated on a single trading day, 31 January 2018, with 4 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The latest filing, published on 1 February 2018, reports an option exercise in Marrone Bio Innovations Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.